3
Announcements
Trials
Browse
Landscape
Status
Completed
74
Recruiting
23
Terminated
11
Active not recruiting
8
Unknown
7
Not yet recruiting
2
Withdrawn
1
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
5
Thoracic
2
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Uterine Cervical Neoplasms
19
Ovarian Neoplasms
9
Uterine Cervical Dysplasia
6
Breast Neoplasms
4
Neoplasms
3
Uterine Neoplasms
2
Triple Negative Breast Neoplasms
2
Prostatic Neoplasms
2
Endometrial Neoplasms
2
Depression
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Colorectal Neoplasms
2
Cervical Cancer Screening
2
Carcinoma, Non-Small-Cell Lung
2
Anxiety Disorders
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Treatment Adherence and Compliance
1
Tinnitus
1
Thyroid Neoplasms
1
Tension-Type Headache
1
Stroke
1
Stress Disorders, Post-Traumatic
1
Stomach Neoplasms
1
Squamous Intraepithelial Lesions of the Cervix
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Stenosis
1
Spinal Cord Injuries
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Kidney Neoplasms
×
Gynecologic
×
Clear all
NCT06885424
2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
400 enrolled